Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy

被引：2
|
作者：
Xie, Yunkai [1 ]
Kong, Weimin [1 ,2 ]
Luo, Dan [1 ]
Chen, Shuning [1 ]
Zhao, Xiaoling [1 ]
Zhang, He [1 ]
机构：
[1] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing Maternal & Child Hlth Care Hosp, Dept Gynecol Oncol, Beijing, Peoples R China
[2] Qi He Lou St, Beijing 100000, Peoples R China
来源：
ANTICANCER RESEARCH | 2023年 / 43卷 / 08期
关键词：
Endometriosis; ovarian clear cell carcinoma; endometriosis-associated ovarian cancer; oxidative stress; review; GLUTATHIONE-PEROXIDASE; 3; PTEN EXPRESSION; ENDOMETRIOSIS; CANCER; PROGRESSION; ADENOCARCINOMA; PROLIFERATION; INHIBITION; RESISTANCE; MUTATIONS;
D O I：
10.21873/anticanres.16515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ovarian clear cell carcinomas (OCCCs) are a subtype of ovarian epithelial tumors that arise from the malignant transformation of endometriosis (EMs). These tumors have distinctive molecular features, high malignant potential, low sensitivity to conventional chemotherapy, and poor prognosis. The process and mechanism of malignant transformation from EMs to OCCCs remains elusive. Elucidation of the molecular pathogenesis and drug resistance mechanism of OCCCs is essential to guide the clinical management and basic research of this disease. This paper provides a comprehensive review of the mechanisms of malignant transformation, genomic characteristics, drug resistance and targeted therapy of OCCCs. The review aims to provide new insights for the clinical management of advanced OCCCs.
引用
收藏
页码：3401 / 3410
页数：10
相关论文
共 50 条
  • [1] New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
    D S P Tan
    R E Miller
    S B Kaye
    British Journal of Cancer, 2013, 108 : 1553 - 1559
  • [2] New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
    Tan, D. S. P.
    Miller, R. E.
    Kaye, S. B.
    BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1553 - 1559
  • [3] Molecular pathogenesis of ovarian clear cell carcinoma
    Gounaris, Ioannis
    Brenton, James D.
    FUTURE ONCOLOGY, 2015, 11 (09) : 1389 - 1405
  • [4] Genomic alterations and outcomes with targeted therapy in patients with clear cell renal cell carcinoma
    Carlo, Marie
    BJU INTERNATIONAL, 2016, 118 : 13 - 13
  • [5] Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing
    Lin, Po-Hung
    Huang, Chao-Yuan
    Yu, Kai-Jie
    Kan, Hung-Cheng
    Liu, Chung-Yi
    Chuang, Cheng-Keng
    Lu, Yu-Chuan
    Chang, Ying-Hsu
    Shao, I-Hung
    Pang, See-Tong
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [6] Evaluation of ATR Inhibitors for Targeted Therapy of Ovarian Clear Cell Carcinoma.
    Ji, Jing
    Li, Zhigui
    Sherman, Emily
    Osagie, Oloruntoba
    Mi, Shijun
    Soble, Whitney
    Li, Jessie
    Huang, Gloria
    REPRODUCTIVE SCIENCES, 2021, 28 (SUPPL 1) : 107A - 107A
  • [7] Evaluation of ATR Inhibitors for Targeted Therapy of Ovarian Clear Cell Carcinoma.
    Ji, Jing
    Li, Zhigui
    Sherman, Emily
    Osagie, Oloruntoba
    Mi, Shijun
    Huang, Gloria
    REPRODUCTIVE SCIENCES, 2020, 27 (SUPPL 1) : 118A - 118A
  • [8] Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy
    Yamashita, Yoriko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (05) : 405 - 407
  • [9] Arginine deprivation as a potential targeted therapy for clear cell ovarian carcinoma.
    Xiao, Jennifer
    Ji, Ye
    Cochrane, Dawn R.
    Tessier-Cloutier, Basile
    Hoang, Lien N.
    Wang, Yikan
    Cheung, Angela
    Chow, Christine
    Colborne, Shane
    Hughes, Christopher
    Morin, Gregg B.
    Huntsman, David G.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 29 - 29
  • [10] CLINICAL AND GENOMIC LANDSCAPE OF OVARIAN CLEAR CELL CARCINOMA
    Cai, Hongbing
    Dai, Mengyuan
    Shi, Yuying
    Ye, Hong
    Wu, Si-Si
    Yuan, Guangwen
    Wu, Lingying
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A134 - A134
12345